Meet The Biosimilars Generation
– In it together
Patients are at the heart of The Biosimilars Generation. Biosimilar medicines are effective biologic treatment options for patients living with chronic, disabling and life-threatening diseases, including inflammatory arthritis, certain types of cancer, diabetes, inflammatory bowel disease and Crohn’s disease.
The decision of a biologic (original-brand or biosimilar) treatment option can be life changing and should be based on a discussion between the doctor and patient and consideration of benefits and risks, treatment goals and tolerance for side effects, accessibility of treatment and affordability.
Healthcare Providers– In it together
Based on extensive research in the lab and in animals, studies in humans, reviews by Health Canada and real-world experience of thousands of patients in Europe and North America, Canadian doctors are prescribing biosimilar medicines to address the needs of their patients living with complex chronic diseases.
The Biosimilars Generation website is sponsored by Sandoz Canada and aims to provide research-based biosimilar information and resources for Canadian patients, healthcare providers and the general public. Sandoz is a global leader in generic medicines and biosimilars. Our commitment is to improve and extend people’s lives by pioneering access for patients with new, affordable medicines that address unmet medical needs. Today, Sandoz has many medicines in its global biosimilar research and development program that focus on specific therapeutic areas, including oncology, immunology, endocrinology and rare diseases.